Go Pro

Mitsubishi UFJ Asset Management Co. Ltd. Takes Position in DaVita Inc. $DVA

DaVita logo with Healthcare background
Image from MarketBeat Media, LLC.

Key Points

  • Mitsubishi UFJ Asset Management acquired 39,712 DaVita shares worth approximately $8.8 million, giving it a 0.06% stake. Institutional investors collectively own 90.12% of the company.
  • DaVita exceeded quarterly expectations, reporting $4.02 in EPS versus the $3.88 consensus and $3.55 billion in revenue, up 5.2% year over year. The company issued fiscal 2026 EPS guidance of $14.10–$15.20.
  • Analyst sentiment remains mixed, with a consensus “Hold” rating and a $221.75 target price; price targets from individual firms range from $220 to $265. An insider also sold 15,405 shares for about $3.2 million.
  • Five stocks to consider instead of DaVita.

Mitsubishi UFJ Asset Management Co. Ltd. purchased a new position in DaVita Inc. (NYSE:DVA - Free Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 39,712 shares of the company's stock, valued at approximately $8,835,000. Mitsubishi UFJ Asset Management Co. Ltd. owned 0.06% of DaVita as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other large investors also recently bought and sold shares of DVA. Invesco Ltd. grew its holdings in shares of DaVita by 2.0% in the third quarter. Invesco Ltd. now owns 1,679,248 shares of the company's stock worth $223,122,000 after purchasing an additional 32,358 shares during the last quarter. Morgan Stanley lifted its holdings in DaVita by 5.1% during the 4th quarter. Morgan Stanley now owns 1,477,045 shares of the company's stock valued at $167,807,000 after buying an additional 71,156 shares in the last quarter. Arrowstreet Capital Limited Partnership grew its stake in DaVita by 114.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,190,000 shares of the company's stock worth $135,196,000 after acquiring an additional 636,191 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of DaVita by 5.2% during the first quarter. Dimensional Fund Advisors LP now owns 1,145,436 shares of the company's stock worth $176,037,000 after acquiring an additional 56,336 shares during the period. Finally, LSV Asset Management increased its position in shares of DaVita by 1.1% during the fourth quarter. LSV Asset Management now owns 936,768 shares of the company's stock worth $106,426,000 after acquiring an additional 9,739 shares during the period. Hedge funds and other institutional investors own 90.12% of the company's stock.

Analyst Ratings Changes

A number of brokerages recently issued reports on DVA. Raymond James Financial set a $220.00 price target on DaVita in a report on Friday, August 7th. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a $265.00 target price on shares of DaVita in a research report on Wednesday, August 5th. Weiss Ratings upgraded DaVita from a "hold (c+)" rating to a "buy (b-)" rating in a report on Wednesday, August 5th. Oppenheimer set a $220.00 price target on DaVita in a research note on Friday, August 7th. Finally, Zacks Research downgraded DaVita from a "strong-buy" rating to a "hold" rating in a report on Monday, July 6th. Four analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $221.75.

Check Out Our Latest Research Report on DVA

Insider Activity at DaVita

In related news, insider Kathleen Alyce Waters sold 15,405 shares of the company's stock in a transaction on Monday, June 15th. The stock was sold at an average price of $208.40, for a total transaction of $3,210,402.00. Following the completion of the sale, the insider directly owned 109,194 shares in the company, valued at $22,756,029.60. This represents a 12.36% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Insiders own 1.90% of the company's stock.

DaVita Stock Performance

NYSE DVA opened at $175.54 on Friday. The company has a market cap of $11.20 billion, a PE ratio of 14.36, a P/E/G ratio of 0.59 and a beta of 0.88. The firm's 50 day moving average price is $215.64 and its 200-day moving average price is $181.58. DaVita Inc. has a 52-week low of $101.00 and a 52-week high of $247.49.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Tuesday, August 4th. The company reported $4.02 EPS for the quarter, topping analysts' consensus estimates of $3.88 by $0.14. The company had revenue of $3.55 billion during the quarter, compared to the consensus estimate of $3.50 billion. DaVita had a net margin of 6.05% and a negative return on equity of 217.63%. DaVita's revenue for the quarter was up 5.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.95 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. On average, analysts forecast that DaVita Inc. will post 14.57 earnings per share for the current fiscal year.

DaVita Company Profile

(Free Report)

DaVita Inc NYSE: DVA is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.

Featured Articles

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA - Free Report).

Institutional Ownership by Quarter for DaVita (NYSE:DVA)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in DaVita Right Now?

Before you consider DaVita, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.

While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines